Chase & Co Jpmorgan reported a 6.3% stake in Keros Therapeutics KROS · 2,587,146 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 6.3%
Last report: First report
Shares held: 2,587,146 sh
Class: Common Stock, $0.0001 par value per share
Stock: Keros Therapeutics KROS
Holder: Chase & Co Jpmorgan
Event date: 25/03/31
Filed: 25/05/02

First 5%+ report · 6.3% stake

Keros Therapeutics trades, last 26 weeks

What else happened in Keros Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

Chase & Co Jpmorgan's other 5% stake reports

Chase & Co Jpmorgan
5% stakeBlackrock Muniholdings Fund
5% stake
Blackrock Muniholdings Fund
MHD
100% stake
7,178 sh
100% stake
Filed 10/01
Chase & Co Jpmorgan
5% stakeCiena
5% stake
Ciena
CIEN
3.9% stake
5,616,378 sh
3.9% stake
Filed 09/03
Chase & Co Jpmorgan
5% stakeVicor
5% stake
Vicor
VICR
4% stake
1,394,339 sh
4% stake
Filed 09/03
Chase & Co Jpmorgan
5% stakeMKS
5% stake
MKS
MKSI
2.9% stake
2,005,756 sh
2.9% stake
Filed 09/03
Chase & Co Jpmorgan
5% stakeLamb Weston Holdings
5% stake
Lamb Weston Holdings
LW
4.9% stake
6,889,942 sh
4.9% stake
Filed 08/05